PACT - Public Activities Coordination Tool

PACT - Public Activities Coordination Tool

PACT - Public Activities Coordination Tool

The public activities coordination tool (PACT) provides an overview of the substance-specific activities that authorities are working on under REACH and the CLP Regulation. These activities are being carried out in line with ECHA’s Integrated Regulatory Strategy.

PACT provides up-to-date information on the activities planned, ongoing or completed by ECHA and/or MSCAs for a given substance in the following areas:

  • Data generation and assessment – dossier evaluation, substance evaluation, informal hazard assessment (PBT/vPvB/ED).
  • Assessment of regulatory needs (ARN).
  • Regulatory risk management – harmonised classification and labelling (CLH) , SVHC identification, recommendations for inclusion in the Authorisation List, restriction.

A summary of all the substance-specific activities can be found under ‘Details’ for each entry.

Filter the list
Latest update:
Process:

The List does not contain any Substances.
Data generation and assessment ARN Regulatory risk management
 
5-hexenyltrimethoxysilane 261-419-4 58751-56-7 - - - - 1 - - - - Details
o-(p-isocyanatobenzyl)phenyl isocyanate 227-534-9 5873-54-1 - 1 1 - 3 - - - - Details
1-(1-oxododecyl)-L-proline 261-407-9 58725-39-6 - - - - 1 - - - - Details
Sodium 5-oxo-1-palmitoyl-L-prolinate 261-406-3 58725-33-0 - - - - 1 - - - - Details
Dilanthanum tricarbonate 209-599-5 587-26-8 - - 3 - 1 - - - - Details
2-decyltetradecanol 261-385-0 58670-89-6 - - 1 - - - - - - Details
reaction mass of: 4-amino-3-(4-ethenesulfonyl-2-sulfonatophenylazo)-5-hydroxy-6-(5-{4-chloro-6-[4-(2-sulfonatooxyethanesulfonyl)phenylamino]-1,3,5-triazin-2-ylamino}-2-sulfonatophenylazo)naphthalene-2,7-disulfonate potassium/sodium 4-amino-5-hydroxy-6-(5-{4-chloro-6-[4-(2-sulfonatooxyethanesulfonyl)phenylamino]-1,3,5-triazin-2-ylamino}-2-sulfonatophenylazo)-3-(2-sulfonato-4-(2-sulfonatooxyethanesulfonyl)phenylazo)naphthalene-2,7-disulfonate potassium/sodium 451-440-9 586372-44-3 - - 1 - 1 - - - - Details
1-methyl-4-(1-methylethylidene)cyclohexan-1-ol 209-584-3 586-81-2 - - - - 1 - - - - Details
1-(4-Methylphenyl)ethylamine 624-212-3 586-70-9 - - - - 1 - - - - Details
1-(4-methylphenyl)ethylamine 443-160-0 586-70-9 - - - - 1 - - - - Details
3-methoxyacetophenone 209-573-3 586-37-8 - - - - 1 - - - - Details
(Z)-13-octadecenal 261-349-4 58594-45-9 - - - - - 1 - - - Details
(ethoxymethoxy)cyclododecane 261-332-1 58567-11-6 - 1 1 - - - - - - Details
tert-butyl methacrylate 209-548-7 585-07-9 - - 1 - 1 - - - - Details
1-chloro-1,2,3,4-tetrahydronaphthalene 611-664-1 58485-68-0 - - - - 1 - - - - Details
3,5,5-trimethylhexyl acetate 261-245-9 58430-94-7 - - 3 - - - - - - Details
4-methyl-m-phenylene diisocyanate 209-544-5 584-84-9 - - 1 - 3 - - - - Details
Butane-1,2-diol 209-527-2 584-03-2 - - - - 1 - - - - Details
Benzyl 2-ethylhexyl adipate 261-234-9 58394-64-2 - - - - 1 - - - - Details
Coumatetralyl 227-424-0 5836-29-3 - - - - - 1 - - - Details
Disodium (Z)-4-(9-octadecenylamino)-4-oxo-2(or 3)-sulphonatobutyrate 261-222-3 58353-68-7 - - 1 - 1 - - - - Details
N,N-dibutyloleamide 227-410-4 5831-80-1 - - - - 1 - - - - Details
2-[(tetrahydrofurfuryl)oxy]ethanol 227-407-8 5831-59-4 - - - - 1 - - - - Details
2-methylcyclohexanone 209-513-6 583-60-8 - - - - 1 - - - - Details
2-methylcyclohexanol, mixed isomers 209-512-0 583-59-5 - - - - 1 - - - - Details
2,3,6-trimethylcyclohexanol 918-414-3 58210-03-0 - - - - 1 - - - - Details
Potassium benzoate 209-481-3 582-25-2 - - 1 - 1 - - - - Details
O,O-bis(2-ethylhexyl) hydrogen dithiophosphate 227-376-0 5810-88-8 - - - - 1 - - - - Details
1,1,3,3-tetramethylbutyl hydroperoxide 227-369-2 5809-08-5 - - 2 - 1 - - - - Details
Theophylline 200-385-7 58-55-9 - - - - 1 1 - - - Details
Caffeine 200-362-1 58-08-2 - - - - 1 - - - - Details
cymoxanil (ISO); 2-cyano-N-[(ethylamino)carbonyl]-2-(methoxyimino)acetamide 261-043-0 57966-95-7 - - - - - 2 - - - Details
acequinocyl (ISO) 3-dodecyl-1,4-dioxo-1,4-dihydronaphthalen-2-yl acetate 611-595-7 57960-19-7 - - - - - 1 - - - Details
o-anisic acid 209-447-8 579-75-9 - - 1 - 1 - - - - Details
2,6-diethylaniline 209-445-7 579-66-8 - - - - 1 - - - - Details
(±)-2-hydroxy-1,2-diphenylethan-1-one 209-441-5 579-44-2 - - - - 1 - - - - Details
Ethyl 4-[[(methylphenylamino)methylene]amino]benzoate 260-976-0 57834-33-0 - - 1 - - - - - - Details
2-methylanisole 209-426-3 578-58-5 - - - - 1 - - - - Details
2-ethylaniline 209-424-2 578-54-1 - - - - 1 - - - - Details
Potassium salicylate 209-421-6 578-36-9 - - - - 1 - - - - Details
benzyl(diethylamino)diphenylphosphonium 4-[1,1,1,3,3,3-hexafluoro-2-(4-hydroxyphenyl)propan-2-yl]phenolate 479-100-5 577705-90-9 - - - - 1 1 - - - Details
Docusate sodium 209-406-4 577-11-7 - - 2 - - - - - - Details
2,6-xylenol 209-400-1 576-26-1 - - 1 - - - - - - Details
Tetraphenyl m-phenylene bis(phosphate) 260-830-6 57583-54-7 - - 1 - 1 - - - - Details
2-ethylhexyl 10-ethyl-4,4-dimethyl-7-oxo-8-oxa-3,5-dithia-4-stannatetradecanoate 260-829-0 57583-35-4 - - 3 - 1 1 - - - Details
2-ethylhexyl 10-ethyl-4-[[2-[(2-ethylhexyl)oxy]-2-oxoethyl]thio]-4-methyl-7-oxo-8-oxa-3,5-dithia-4-stannatetradecanoate 260-828-5 57583-34-3 1 - 2 - - 1 - - - Details
1-[1,6-dimethyl-4-(4-methylpent-3-enyl)-3-cyclohexen-1-yl]ethan-1-one 260-772-1 57499-57-7 - - - - 1 - - - - Details
Oxybis(methyl-2,1-ethanediyl) diacrylate 260-754-3 57472-68-1 - - 1 - 1 - - - - Details
Magnesium neodecanoate 260-742-8 57453-97-1 - - - - 1 - - - - Details
1-(2,6,6-trimethyl-3-cyclohexen-1-yl)-2-buten-1-one 260-709-8 57378-68-4 - - - - 1 - - - - Details

Export search results to: